startup job spotlight

S|W: The SaaS Weekly – Prodigy’s got a new plan, a new CFO, and a leaner team to boost growth

Plus: It’s getting (slightly) easier to sell software.

H|T: The Healthtech Times – AI takeover: predictive pitfall or “medicine’s biggest moment” since antibiotics?

Plus: Quebec City-based OpSens acquired by US firm in $345M deal.

R|T: The Retail Times – Inside the chaos of New York’s Airbnb ban

Plus: Flexport continues weekly cuts with 20 percent workforce reduction.

A|I: The AI Times – OpenAI passes $1.3B annualized revenue while Big Tech struggles to turn AI hype into profits

Plus: Canadian quantum group appoints its first CEO.

S|W: The SaaS Weekly – Atlassian to buy video messaging provider Loom for nearly $1 billion

Plus: Vendasta closes $20M in new funding following layoffs.

R|T: The Retail Times – Canadian-founded company behind Instant Pot files for bankruptcy

Plus: Shopify partners with Volt to offer open banking solutions (but not in Canada).

Collision will remain in Toronto for 2024

Tech conference inks one-year extension, but Collision’s long-term future in Canada still unclear.

Mayor Tory’s departure, competing bids, and financial pressure on province and feds place Collision’s future in Canada in doubt

…

Alberta’s tech sector remained resilient in first quarter of 2023

Jobber’s megadeal pushed venture funding over $200 million in the first three months of the year.

S|W: The SaaS Weekly – Magnet shareholders ignore critics, back acquisition

How 1Password plans to build a passwordless future.

BC venture funding fell to a seven-quarter low in Q3 2022

Investor sentiment goes from FOMO to fussy as deal volume falls to three-year low.

H|T: The Healthtech Times – AlayaCare makes cuts as revenue doesn’t follow “aggressive investment”

Plus: Nurses say Amazon’s ambitions clash with health best practices.

Armed with more capital to back women entrepreneurs, Phoenix Fire makes first investment in VoxCell

Phoenix Fire’s LPs now include the co-founders of Thinkific and Odaia.

Bootstrapped since 2008, Evidence Partners closes $20 million to tackle automated literature review market

Evidence Partners caters to more than 60% of the world’s largest pharma, medical device companies.

BC venture funding starts 2022 strong, but are later-stage companies raising at yesterday’s prices?

VCs say price uncertainty creating a “standstill” between investors and late-stage firms.